Quantcast

Latest Eisai Stories

2015-04-30 12:33:28

WOODCLIFF LAKE, N.J., April 30, 2015 /PRNewswire/ -- Eisai Inc. and Eisai Co., Ltd.

2015-04-29 23:03:37

RnRMarketResearch.com adds “Metastatic Ovarian Cancer – Pipeline Review, H1 2015” to its store.

2015-04-21 23:02:44

RnRMarketResearch.com adds “Dermatitis – Pipeline Review, H1 2015” to its store.

2015-04-20 12:35:05

DUBLIN, April 20, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zbfftz/cns_therapeutics) has announced the addition of the "CNS

2015-04-16 12:35:39

DALLAS, April 16, 2015 /PRNewswire/ -- RnRMarketResearch.com adds 2015 EpiCast Report on Alzheimer's Disease - Epidemiology Forecast to 2023 of 82 pages to the Alzheimer

2015-04-15 08:31:51

LUGANO, Switzerland and WOODCLIFF LAKE, N.J., April 15, 2015 /PRNewswire/ -- Helsinn Group and Eisai Inc.

2015-04-10 08:24:59

-- New Drug Application for once-daily formulation of lorcaserin expected to be submitted to the FDA later this year -- WOODCLIFF LAKE, N.J.

2015-04-09 16:30:10

WOODCLIFF LAKE, N.J., April 9, 2015 /PRNewswire/ -- Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd., today announced plans to realign its operations in the United States.

2015-03-30 08:32:36

Clinical Study (003-011) to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination with Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD)

2015-03-23 23:03:56

RnRMarketResearch.com adds “Arterial Thrombosis – Pipeline Review, H1 2015” report to its store.